Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Pharmacokinetics and tolerability of exemestane in combination with raloxifene in postmenopausal women with a history of breast cancer.

Traina TA, Poggesi I, Robson M, Asnis A, Duncan BA, Heerdt A, Dang C, Lake D, Moasser M, Panageas K, Borgen P, Norton L, Hudis C, Dickler MN.

Breast Cancer Res Treat. 2008 Sep;111(2):377-88. Epub 2007 Oct 20.

PMID:
17952589
2.

Clinical pharmacodynamic effects of the growth hormone receptor antagonist pegvisomant: implications for cancer therapy.

Yin D, Vreeland F, Schaaf LJ, Millham R, Duncan BA, Sharma A.

Clin Cancer Res. 2007 Feb 1;13(3):1000-9.

3.

Phase 1 and pharmacokinetic study of intravenous irinotecan in refractory solid tumor patients with hepatic dysfunction.

Schaaf LJ, Hammond LA, Tipping SJ, Goldberg RM, Goel R, Kuhn JG, Miller LL, Compton LD, Cisar LA, Elfring GL, Gruia G, McGovren JP, Pirotta N, Yin D, Sharma A, Duncan BA, Rothenberg ML.

Clin Cancer Res. 2006 Jun 15;12(12):3782-91.

4.

A phase I and pharmacokinetic study of a powder-filled capsule formulation of oral irinotecan (CPT-11) given daily for 5 days every 3 weeks in patients with advanced solid tumors.

Pitot HC, Adjei AA, Reid JM, Sloan JA, Atherton PJ, Rubin J, Alberts SR, Duncan BA, Denis L, Schaaf LJ, Yin D, Sharma A, McGovren P, Miller LL, Erlichman C.

Cancer Chemother Pharmacol. 2006 Aug;58(2):165-72. Epub 2005 Nov 19.

PMID:
16328416
5.

Myopathy related to administration of a cationic amphiphilic drug and the use of multidose drug distribution analysis to predict its occurrence.

Vonderfecht SL, Stone ML, Eversole RR, Yancey MF, Schuette MR, Duncan BA, Ware JA.

Toxicol Pathol. 2004 May-Jun;32(3):318-25.

PMID:
15204973
6.

Pharmacokinetics and renal effects of cidofovir with a reduced dose of probenecid in HIV-infected patients with cytomegalovirus retinitis.

Wolf DL, Rodríguez CA, Mucci M, Ingrosso A, Duncan BA, Nickens DJ.

J Clin Pharmacol. 2003 Jan;43(1):43-51.

PMID:
12520627
7.

Early diagnosis and management of Alzheimer's disease.

Duncan BA, Siegal AP.

J Clin Psychiatry. 1998;59 Suppl 9:15-21. Review.

8.

A sequential, test-control methodology for conducting functional analyses of self-injurious behavior.

Iwata BA, Duncan BA, Zarcone JR, Lerman DC, Shore BA.

Behav Modif. 1994 Jul;18(3):289-306.

PMID:
8037650
9.

Lacidipine metabolism in rat and dog: identification and synthesis of main metabolites.

Grossi P, Pellegatti M, Vigelli G, Ayrton J, Duncan BA, Evans GL, Maltas J.

Xenobiotica. 1992 Aug;22(8):899-916.

PMID:
1413880
10.

Dantrolene sodium and dystrophia myotonica.

Dawson AD, Duncan BA.

Anaesthesia. 1985 Jun;40(6):596-7. No abstract available.

11.

Modifying eating behavior in anorexia nervosa.

Schmidt MP, Duncan BA.

Am J Nurs. 1974 Sep;74(9):1646-8. No abstract available.

PMID:
4496564

Supplemental Content

Loading ...
Support Center